Carrier-state of the A allele of – 455G>A polymorphism within the beta fibrinogen gene increases the risk of coronary artery disease in the presence of elevated concentration of serum triacylglycerols
 
Więcej
Ukryj
1
Department of Biochemistry and Medical Genetics, School of Health Care, Medical University of Silesia, Katowice, Poland
 
2
The First Department of Cardiac Surgery, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland
 
 
Autor do korespondencji
Beata Sarecka-Hujar   

Department of Biochemistry and Medical Genetics, School of Health Care Medical University of Silesia, Kasztanowa Str. 3, 41-200 Sosnowiec, Poland; phone: (+48 32) 269 98 20
 
 
Ann. Acad. Med. Siles. 2009;63:41-49
 
SŁOWA KLUCZOWE
STRESZCZENIE
Wstęp:
Fibrynogen promuje rozwój zmian miażdżycowych przez przyleganie do zmienionej ściany tętnic gdzie jest przekształcany w fi brynę. Celem niniejszej pracy była ocena związku między polimorfi zmem –455G>A genu kodującego łańcuch beta fi brynogenu (FGB) a ryzykiem choroby wieńcowej (CAD, ang. coronary artery disease) w grupie pacjentów z Górnego Śląska i ustalenie czy istnieją interakcje między tym polimorfi zmem a tradycyjnymi czynnikami ryzyka miażdżycy w determinowaniu ryzyka CAD.

Materiał i metody:
Grupę badaną stanowiło: 191 pacjentów z potwierdzoną koronarograficznie CAD oraz 203 krwiodawców bez obciążeń chorobami sercowo-naczyniowymi. Polimorfizm –455G>A genu FGB genotypowano metodą RFLP-PCR. Wyniki. Częstości genotypów polimorfizmu -455G>A genu FGB były zgodne z równowagą Hardy-Weinberg’a. Nie stwierdzono znamiennych różnic w częstości allela A i nosicieli allela A polimorfizmu genu FGB między pacjentami a grupą kontrolną. Obserwowano tendencję do występowania wyższego poziomu fi brynogenu w osoczu osób z genotypami AA i GA w porównaniu do poziomu fi brynogenu w osoczu osób z genotypem GG. Stwierdzono również silny synergiczny efekt między nosicielstwem allela A a podwyższonym poziomem triglicerydów w determinowaniu ryzyka CAD (indeksy synergii SI=5.97, SIM=2.63). Nosiciele allela A charakteryzujący się podwyższonym poziomem triglicerydów występowali trzykrotnie częściej w grupie chorych niż w kontroli (12.0% vs 3.9%, p=0.003,OR=3.34).

Wyniki:
Przedstawione wyniki wskazują na synergiczny związek nosicielstwa allela A polimorfizmu – 455G>A genu FGB z ponadnormatywnym stężeniem triglicerydów w surowicy krwi w kształtowaniu ryzyka CAD w populacji pacjentów z Górnego Śląska.

ISSN 0208-5607
 
REFERENCJE (36)
1.
Chung D.W., Harris J.E., Davie E.W. Nucleotide sequences of the three genes coding for human fi brinogen. Adv. Exp. Med. Biol. 1990; 281: 39-48.
 
2.
Zhang J.Z., Redman C.M. Identifi cation of B beta chain domains involved in human fi brinogen assembly. J. Biol. Chem. 1992; 267: 21727-21732.
 
3.
Bazzano L.A., He J., Muntner P., Vupputuri S., Whelton P.K. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann. Intern. Med. 2003; 138: 891-897.
 
4.
Thomas A.E., Green F.R., Kelleher C.H. i wsp. Variation in the promoter region of the beta fi brinogen gene is associated with plasma fi brinogen levels in smokers and non-smokers. Thromb. Haemost. 1991; 65:487-490.
 
5.
Tybjaerg-Hansen A., Agerholm-Larsen B., Humphries S.E., Abildgaard S., Schnohr P., Nordestgaard B.G. A common mutation (G-455--> A) in the beta-fi brinogen promoter is an independent predictor of plasma fi brinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study. J. Clin. Invest. 1997; 99: 3034- 3039.
 
6.
Smith E.B., Keen G.A., Grant A., Stirk C. Fate of fi brinogen in human arterial intima. Arteriosclerosis 1990; 10:263-275.
 
7.
Lindsberg P.J., Grau A.J. Infl ammation and infections as risk factors for ischemic stroke. Stroke 2003; 34: 2518-2532.
 
8.
Behague I., Poirier O., Nicaud V. i wsp. Beta fi brinogen gene polymorphisms are associated with plasma fi brinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l‘Infarctus du Myocarde. Circulation 1996; 93: 440-449.
 
9.
Hamsten A., Iselius L., de Faire U., Blomback M. Genetic and cultural inheritance of plasma fi brinogen concentration. Lancet 1987; 2: 988-991.
 
10.
Dalmon J., Laurent M., Courtois G. The human beta fi brinogen promoter contains a hepatocyte nuclear factor 1-dependent interleukin-6-responsive element. Mol. Cell Biol. 1993; 13: 1183-1193.
 
11.
Judkin M.P., Gander M.P. Prevention of complications of coronary arteriography. Circulation 1974; 49: 599-602.
 
12.
Alpert J.S., Thygesen K. Myocardial infarction redefi ned – A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefi nition of Myocardial Infarction. Eur. Heart J. 2000; 21: 1502-1513.
 
13.
Sarecka-Hujar B., Zak I., Krauze J. Interactions between rs5498 polymorphism in the ICAM1 gene and traditional risk factors infl uence susceptibility to coronary artery disease. Clin. Exp. Med. 2009; 9:117-124.
 
14.
Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of preparative centrifuge. Clin. Chem. 1972; 18: 499- 502.
 
15.
Nishiuma S., Kario K., Yakushijin K. i wsp. Genetic variation in the promoter region of the beta-fi brinogen gene is associated with ischemic stroke in a Japanese population. Blood Coagul. Fibrinolysis 1998; 9:373-379.
 
16.
Rothman K.J. Synergy and antagonism in cause-eff ect relationship. Am. J. Epidemiol. 1974; 99: 385-388.
 
17.
Khoury M.J., Flanders W.D. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls! Am. J. Epidemiol. 1996; 144: 207-213.
 
18.
Lam K.S., Ma O.C., Wat N.M., Chan L.C., Janus E.D. Beta-fi brinogen gene G/A-455 polymorphism in relation to fi brinogen concentrations and ischaemic heart disease in Chinese patients with type II diabetes. Diabetologia 1999; 42: 1250-1253.
 
19.
de Maat M.P., Kastelein J.J., Jukema J.W. i wsp. -455G/A polymorphism of the beta-fi brinogen gene is associated with the progression of coronary atherosclerosis in symptomatic men: proposed role for an acute-phase reaction pattern of fi brinogen. REGRESS group. Arterioscler. Thromb. Vasc. Biol. 1998; 18: 265-271.
 
20.
Bi S., Wang D., Li G., Wen S., Pan S. Beta-fi brinogen promoter -455 G/A (HaeIII) polymorphism prediction of plasma fi brinogen but not of ischemic cerebrovascular disease. Chin. Med. Sci. J. 2004; 19: 1-5.
 
21.
Ando R., Doi M., Yamauchi K. i wsp. Association of beta-fi brinogen and factor VII polymorphism with plasma fi brinogen and factor VII levels, and no association of PAI-1 polymorphism with plasma PAI-1 levels in hemodialysis patients. Clin. Nephrol. 2002; 58: 25-32.
 
22.
Lee A.J., Fowkes F.G., Lowe G.D., Connor J.M., Rumley A. Fibrinogen, factor VII and PAI-1 genotypes and the risk of coronary and peripheral atherosclerosis: Edinburgh Artery Study. Thromb. Haemost. 1999; 81: 553-560.
 
23.
de Maat M.P., de Knijff P., Green F.R., Thomas A.E., Jespersen J., Kluft C. Genderrelated association between beta-fi brinogen genotype and plasma fi brinogen levels and linkage disequilibrium at the fi brinogen locus in Greenland Inuit. Arterioscler. Thromb. Vasc. Biol. 1995; 15: 856-860.
 
24.
Thomas A., Lamlum H., Humphries S., Green F. Linkage disequilibrium across the fi brinogen locus as shown by fi ve genetic polymorphisms, G/A-455 (HaeIII), C/T- 148 (HindIII/AluI), T/G+1689 (AvaII), and BclI (beta-fi brinogen) and TaqI (alphafi brinogen), and their detection by PCR. Hum. Mutat. 1994; 3: 79-81.
 
25.
Mannila M.N., Lovely R.S., Kazmierczak S.C. i wsp. Elevated plasma fi brinogen gamma‘ concentration is associated with myocardial infarction: eff ects of variation in fibrinogen genes and environmental factors. J. Thromb. Haemost. 2007; 5: 766-773.
 
26.
Leander K., Wiman B., Hallqvist J., Falk G., De Faire U. The G-455A polymorphism of the fi brinogen Bbeta-gene relates to plasma fi brinogen in male cases, but does not interact with environmental factors in causing myocardial infarction in either men or women. J. Intern. Med. 2002; 252: 332-341.
 
27.
Bots M.L., Elwood P.C., Salonen J.T. i wsp. Level of fi brinogen and risk of fatal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe. J. Epidemiol. Community Health 2002; 56 Suppl 1: i14-8.
 
28.
Mills J.D., Ariens R.A., Mansfi eld M.W., Grant P.J. Altered fi brin clot structure in the healthy relatives of patients with premature coronary artery disease. Circulation 2002; 106: 1938-1942.
 
29.
Weng X., Cloutier G., Genest J. Jr. Contribution of the -455G/A polymorphism at the betafi brinogen gene to erythrocyte aggregation in patients with coronary artery disease. Thromb. Haemost. 1999; 82:1406- 1411.
 
30.
Scarabin P.Y., Aillaud M.F., Amouyel P. i wsp. Associations of fi brinogen, factor VII and PAI-1 with baseline fi ndings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction. Thromb. Haemost. 1998; 80: 749-756.
 
31.
Boekholdt S.M., Bijsterveld N.R., Moons A.H., Levi M., Buller H.R., Peters R.J. Genetic variation in coagulation and fi brinolytic proteins and their relation with acute myocardial infarction: a systematic review. Circulation 2001; 104: 3063-3068.
 
32.
Koch W., Hoppmann P., Biele J., Mueller J.C., Schömig A., Kastrati A. Fibrinogen genes and myocardial infarction: a haplotype analysis. Arterioscler. Thromb. Vasc. Biol. 2008; 28: 758-763.
 
33.
Choumerianou D.M., Maumus S., Skoumas J. et all. Polymorphisms associated with apolipoprotein B levels in Greek patients with familial hypercholesterolemia. Clin. Chem. Lab. Med. 2006; 44: 799- 806.
 
34.
Zak I., Sarecka-Hujar B., Krauze J. Cigarette smoking, carrier state of A or G allele of 46A>G and 79C>G polymorphisms of beta2-adrenergic receptor gene, and the risk of coronary artery disease. Kardiol. Pol. 2008; 66: 380-386.
 
35.
Zak I., Sarecka-Hujar B., Krauze J. Relationships between traditional risk factors and carrier-state of C allele of 1059G>C polymorphism in the C-reactive protein gene and the risk of coronary artery disease. Ann. Acad. Med. Siles. 2008; 62: 27- 33.
 
36.
Zak I., Sarecka B., Krauze J. Synergistic eff ects between 561A >C and 98G> T polymorphisms of E-selectin gene and hypercholesterolemia in determining the susceptibility to coronary artery disease. Heart Vessels 2008; 23: 257-263.
 
eISSN:1734-025X
Journals System - logo
Scroll to top